Lumpy skin disease (LSD) is a highly infectious viral disease of cattle caused by LSD virus (LSDV), which was first reported in Armenia in late 2015. It was identified in pasture-raised cattle near the border with Iran. Currently, vaccination plays a key role in preventing further incursion of disease in high-risk areas. The purpose of this work was to assess the quality of vaccination currently used in Armenia by determining the immune response of the heterologous dry culture sheep pox virus-based vaccine against LSD in cattle. Seroprevalence and seroconversion testing was carried out using an ELISA to detect specific antibodies against LSD before and 30 days after vaccination in three adjacent regions of Armenia (Ararat, Armavir, Gegharkunik). Ixodes ticks were also examined for the presence of LSDV via real-time PCR. We found that the heterologous vaccine used in Armenia creates a high level of population immunity of 86.09% (83.83–87.97%) and no adverse side effects were observed in cattle. Of the 6 types of Ixodes ticks identified and tested, we found no evidence of LSDV circulating in these vectors. These results suggest that regular serological monitoring via ELISA and heterologous vaccination should continue in areas of Armenia at high risk for incursion of LSD to reduce the spread of this highly infectious transboundary disease.

Background: Foot-and-mouth disease (FMD) is a high impact viral disease of livestock for which vaccines are extensively used for limiting the spread of infection. Armenia shares a border with both Turkey and Iran where FMD is endemic, making vaccination an important component of Armenia’s control strategy. Additionally, Armenian veterinary services utilize both passive and active monitoring for prevention control. Methods: We sought to determine the immune status of animals vaccinated against FMD and to evaluate the effectiveness of our vaccination policy in Armenia. This was conducted in three regions including Shirak, Armavir, and Ararat Region which are located in the buffer zones that border Turkey and Iran. Through active monitoring in 2020, we studied blood serum samples from cattle and sheep using an enzyme immunoassay to determine the level of immune animals in these regions following the use of a polyvalent inactivated vaccine containing FMDV serotypes A, O, and Asia-1 that are relevant for this region. ELISA titers were assessed at 28, 90, and 180 days after vaccination in cattle of three age groups at the time of initial vaccination: 4–6 months, 6–18 months and ≥ 24 months of age with sheep of all ages. Results: The 3 age groups of cattle had similarly high levels of immunity with over 90% of the cattle showing a ≥ 50% protective titer 28 days after the first vaccination. By day 90, titers in cattle from the initial 4–18-month age groups dropped below 58% across the 3 serotypes and at or below 80% for the oldest cattle ≥ 24 months. Re-vaccination of cattle at 120 days did improve protective titers but never reached the level of immunity of the first vaccination. Sheep showed a similar rapid drop to less than 50% having a ≥ 50% protective titer at 90 days emphasizing the need for continual revaccination. Conclusions: The results of this study have important implications for the current FMD vaccine policy in Armenia and improves our understanding of the rapid loss of protective titers over short periods. Since small ruminants are only vaccinated once per year and vaccination titers drop rapidly by 90 days suggests that they are vulnerable to FMD and that vaccination protocols need to be updated. Cattle should continue to be vaccinated every 3–6 months depending on their age to maintain a protective level of antibodies to protect them from FMD. More studies are needed to understand the possible role of small ruminants in the epidemiology of FMD and to evaluate revaccination at shorter intervals. These results show the concerns of rapid loss of protection to both cattle and small ruminants following 1 or more doses of commercial vaccines and that additional vaccines need to be evaluated in both groups to know how often they must be vaccinated to provide full protection. The addition of challenge studies should also be considered to better understand the level of protection as measured by serology and how it relates to protection from challenge. These results should be considered by anyone using these vaccines in cattle and sheep at longer than 3 month intervals.

The transmission of lumpy skin disease (LSD) occurs through ticks, mosquitoes, and flies. The most effective way to combat LSD is to conduct large-scale vaccination, covering the entire cattle population with safe and effective vaccines, while introducing restrictions on the movement of livestock. The first and only LSD cases that occurred in Armenia happened in 2015,and they were controlled with the use of a once yearly heterologous sheep pox vaccine for cattle in high-risk areas. We have previously reported on the safety and immunogenicity of this vaccine in cattle, but information on the duration of immunity is lacking. Our aim was to determine the duration of immunity to the LSD virus (LSDV) in cattle when utilizing a heterologous sheep pox vaccine. We have evaluated antibodies in cattle blood prior to and post-vaccination (1, 6, and 11 months). We have utilized an enzyme-linked immunosorbent assay to follow the development and waning of LSDV antibodies in vaccinated cattle in two age groups: 1) young unvaccinated cattle ≤12 months of age and 2) adult cattle that had previously been vaccinated. Our results were consistent with our previous study in Armenia, showing a high level of population immunity, 80.0–83.3%, in both age groups at 1 month, with a significant (p = 0.001) drop for young cattle at 6 months. Previously vaccinated adult cattle showed a longer duration of immunity at 11 months for this heterologous sheep pox vaccine. Based on these data, we advise that young cattle receive an additional booster vaccination 4–6 months after their first vaccination, and then yearly vaccinations in high-risk areas.

Introduction: Anthrax is a World Organisation for Animal Health (WOAH)‐listed disease that must be reported upon confirmation based on the Terrestrial Animal Health Code. Anthrax poses a serious health issue for unvaccinated livestock, is a threat to humans through interaction with contaminated livestock and animal products and is endemic in many areas throughout the world, including the Transcaucasian Region. Despite several control and eradication efforts that have been implemented by the government of the Republic of Armenia (RA), sporadic cases of anthrax are still reported. We sought to understand the epidemic situation of anthrax in RA during the last 10 years (2012–2023) based on analysis of outbreaks and reported cases in cattle and humans.Methods: We collected and evaluated officially reported data from human and animal cases, such as time, location, animal species, disease intensity and spread radius. The data and various parameters were mapped using ArcGIS to prepare a viable risk assessment.Results: Based on the officially available data and reports, there have been 80 human cases and 55 animal cases of anthrax confirmed in RA from 2012 to 2023. We also identified the presence of anthrax spores in soil and environmental samples near animal burial sites in RA in 2015–2017 through polymerase chain reaction (PCR) testing. Upon comparing the human and animal cases by frequency and intensity, the human cases are directly proportional to the animal husbandry practices performed in RA.Conclusion: The detection of the anthrax pathogen at the burial sites highlights the continued threat in these areas. Thus, it is imperative to secure and monitor any areas that have been used for anthrax burial and limit the movement of animals in these areas. In the future, legislation should be updated to prioritise incineration of anthrax‐infected carcasses instead of burial to limit further exposure to animals and humans.

In countries endemic for foot-and-mouth disease (FMD), routine or emergency vaccinations are strategic tools to control the infection. According to the WOAH/FAO guidelines, a prior estimation of vaccine effectiveness is recommendable to optimize control programs. This study reports the results of a small-scale immunogenicity study performed in Transcaucasian Countries. Polyvalent vaccines, including FMDV serotypes O, A (two topotypes) and Asia1 from two different manufacturers, were evaluated in Georgia, Azerbaijan and Armenia. Naïve large and small ruminants were vaccinated once and a subgroup received a second booster dose. The titers of neutralizing antibodies in sera collected sequentially up to 180 DPV were determined through the Virus Neutralization Test versus homologous strains. This study led to the estimate that both the vaccines evaluated will not induce a protective and long-lasting population immunity, even after a second vaccination, stressing that consecutive administrations of both vaccines every three months are mandatory if one aspires to achieve protective herd immunity.

KEEN The factors associated with the spread and persistence of African swine fever (ASF) in the Caucasus region remain to be fully identified. It is assumed that large naive populations of domestic free-ranging and wild pigs are critical to disease transmission and maintenance. Nonetheless, 11 years since its epidemic introduction into the region in 2007, ASF virus (ASFV) is still circulating, suggesting that an endemic cycle has been established based on contact between free-ranging domestic pigs and wild pigs, and that native Ornithodoros ticks probably serve as reservoirs for the virus. Therefore, research is required to gather information on the epidemiological status of ASF in the Caucasus region, focusing particularly on understanding modes of ASFV spread and persistence in this new virus environment. The authors established an ASFV survey targeting domestic pigs in the Tavush province of northern Armenia, an area of the country considered to be at high risk of disease incursion/occurrence. All tested samples collected for this survey were negative for ASF. The probability of observing no reactors by antibody enzyme-linked immunosorbent assay in a sample of this size (n = 1,506) from a population with an estimated disease prevalence of 1% is very low (< 0.0001). Therefore, it is possible but very unlikely for ASFV to be present among domestic pigs in the Tavush province region. Aún no están perfectamente identificados los factores que intervienen en la propagación y persistencia de la peste porcina africana (PPA) en la región del Cáucaso. Se presupone que la existencia de grandes poblaciones de cerdos salvajes y cerdos domésticos en libertad que no han estado expuestas previamente al patógeno es un factor crucial en la transmisión y el mantenimiento de la enfermedad. Sin embargo, 11 años después de su penetración epidémica en la región, en 2007, el virus de la PPA aún sigue en circulación, hecho que parece apuntar al establecimiento de un ciclo endémico mediado por el contacto entre cerdos domésticos en libertad y cerdos salvajes y también a la probable función de la garrapata autóctona Ornithodoros como reservorio del virus. Por consiguiente, es necesario investigar para reunir información sobre la situación epidemiológica de la PPA en la región del Cáucaso, procurando especialmente aprehender las modalidades de propagación y persistencia del virus en este nuevo entorno. Los autores estudiaron la presencia del virus de la PPA específicamente en cerdos domésticos de la provincia de Tavush, al norte de Armenia, una zona del país considerada muy expuesta al riesgo de incursión o manifestación de la enfermedad. Todas las muestras obtenidas y analizadas para el estudio dieron resultado negativo a la PPA. La probabilidad de no detectar con ELISA ningún ejemplar con anticuerpos en una muestra de tal tamaño (n = 1 506), tomada de una población con una prevalencia de la enfermedad que según los cálculos es del 1%, resulta ínfima (<0,0001). Es por lo tanto posible, pero harto improbable, que el virus de la PPA esté presente en los cerdos domésticos de la zona de la provincia de Tavush. Les facteurs associés à la propagation de la peste porcine africaine (PPA) dans le Caucase et à sa persistance restent en grande partie à élucider. On suppose que la présence de populations naïves de porcs domestiques en liberté et de porcs sauvages joue un rôle déterminant dans la transmission et le maintien de la maladie. Néanmoins, 11 ans après son introduction épidémique dans la région en 2007, le virus de la peste porcine africaine (VPPA) est toujours présent, ce qui laisse penser qu’un cycle s’est installé à la faveur des contacts entre les porcs domestiques en liberté et les porcs sauvages, les tiques autochtones Ornithodoros faisant probablement office de réservoir viral. Des études sont donc nécessaires pour recueillir des informations sur le statut épidémiologique de la PPA dans le Caucase et plus particulièrement pour comprendre les modalités de la propagation et de la persistance du VPPA dans ce nouvel environnement. Les auteurs rapportent les résultats d’une enquête épidémiologique sur le VPPA conduite chez les porcs domestiques de la province du Tavush, au nord de l’Arménie, zone considérée comme présentant un risque élevé d’incursion et d’émergence de la maladie. Les échantillons prélevés à cette fin ont tous donné des résultats négatifs au test de détection de la PPA. La probabilité qu’un échantillon de cette taille (n = 1 506) ne donne aucune réaction positive à l’épreuve ELISA de détection d’anticorps dans une population pour laquelle la prévalence de la maladie est estimée à 1 % est extrêmement faible (< 0,0001). On peut en conclure que la présence du VPPA parmi les porcs domestiques de la région du Tavush est possible, mais très improbable.